Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Hohloch · SciRah

Researcher profile · Semantic Scholar

K. Hohloch

Share profile

K. Hohloch — researcher profile on SciRah

h-index: 16
Works: 57
Citations: 1,253

Most-cited papers

Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
S. Stilgenbauer, T. Zenz, D. Winkler, A. Bühler +15 more
2009Journal of Clinical Oncology289 citations Open access
Semantic Scholar
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
C. Buske, E. Hoster, M. Dreyling, H. Eimermacher +16 more
2009Leukemia153 citations
Semantic Scholar
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
C. Kollmannsberger, J. Beyer, R. Liersch, P. Schoeffski +8 more
2004Journal of Clinical Oncology144 citations Open access
Semantic Scholar
Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa
Christiane Wolz, K. Hohloch, Aydin Z. Ocaktan, K. Poole +5 more
1994Infection and Immunity79 citations Open access
Semantic Scholar
Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.
A. Meyer, Andrea Stroux, K. Lerch, J. Eucker +7 more
2014Annals of Oncology57 citations Open access
Semantic Scholar
Population Pharmacokinetics of Melphalan and Glutathione S‐transferase Polymorphisms in Relation to Side Effects
A. Kühne, O. Sezer, U. Heider, I. Meineke +7 more
2008Clinical pharmacology and therapy48 citations Open access
Semantic Scholar
Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms.
M. Tzvetkov, Gerrit Behrens, V. P. O'Brien, K. Hohloch +2 more
2011Pharmacogenomics (London)46 citations
Semantic Scholar
Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma
K. Herfarth, P. Borchmann, S. Schnaidt, K. Hohloch +16 more
2018HemaSphere45 citations Open access
Semantic Scholar
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
M. Fürstenau, P. Langerbeins, Nishanthi De Silva, A. Fink +18 more
2020Leukemia42 citations Open access
Semantic Scholar
Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan
A. Kühne, R. Kaiser, M. Schirmer, U. Heider +7 more
2007Pharmacogenetics & Genomics35 citations
Semantic Scholar
Lichen planus with Oesophageal Involvement
M. Menges, K. Hohloch, W. Pueschel, A. Stallmach
2002Digestion30 citations
Semantic Scholar
Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection
Katarzyna Szajek, Marie-Elisabeth Kajdi, Valerie Luyckx, T. Fehr +4 more
2021BMC Nephrology26 citations Open access
Semantic Scholar
Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))
K. Herfarth, M. Engelhard, P. Borchmann, K. Hohloch +6 more
201220 citations
Semantic Scholar
Lichen planus with oesophageal involvement. A case report and review of the literature.
M. Menges, K. Hohloch, W. Pueschel, A. Stallmach
2002Digestion19 citations
Semantic Scholar
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
L. Trumper, C. Zwick, M. Ziepert, K. Hohloch +11 more
2007Annals of Oncology18 citations Open access
Semantic Scholar
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with 131I-anti-CD20 antibody and stem cell rescue
K. Hohloch, C. Sahlmann, Vijai J. Lakhani, G. Wulf +6 more
2011Annals of Hematology16 citations Open access
Semantic Scholar
Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group
K. Hohloch, M. Ziepert, L. Truemper, C. Buske +4 more
2020eJHaem15 citations Open access
Semantic Scholar
Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases
K. Hohloch, Nick Bertram, L. Trumper, T. Beissbarth +1 more
2014Journal of Cancer Research and Clinical Oncology15 citations Open access
Semantic Scholar
Radioimmunotherapy Confers Long-Term Survival to Lymphoma Patients with Acceptable Toxicity: Registry Analysis by the International Radioimmunotherapy Network
K. Hohloch, A. Delaloye, C. Windemuth-Kieselbach, J. Gomez-Codina +6 more
2011Journal of Nuclear Medicine15 citations Open access
Semantic Scholar
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network
K. Hohloch, H. K. Lankeit, P. Zinzani, C. Scholz +3 more
2014European Journal of Nuclear Medicine and Molecular Imaging14 citations Open access
Semantic Scholar
Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
S. Gregory, K. Hohloch, C. Gisselbrecht, K. Tobinai +1 more
2009The Oncologist14 citations Open access
Semantic Scholar
Obesity negatively impacts outcome in elderly female patients with aggressive B‐cell lymphomas treated with R‐CHOP : results from prospective trials of the German high grade non‐Hodgkin's lymphoma trial group
K. Hohloch, B. Altmann, M. Pfreundschuh, M. Loeffler +4 more
2018British Journal of Haematology13 citations
Semantic Scholar
Ibrutinib‐induced rapid response in chemotherapy‐refractory Richter's syndrome
A. Fischer, S. Bastian, S. Cogliatti, U. Mey +4 more
2018Hematological Oncology11 citations
Semantic Scholar
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma
A. Stathis, U. Mey, S. Schär, F. Hitz +21 more
2022Blood Advances10 citations Open access
Semantic Scholar
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL
K. Hohloch, C. Zwick, M. Ziepert, D. Hasenclever +9 more
2014SpringerPlus10 citations Open access
Semantic Scholar
Yttrium 90 ibritumomab tiuxetan (Zevalin®): A new bullet in the fight against malignant lymphoma?
B. Chapuy, K. Hohloch, L. Trumper
2007Biotechnology Journal10 citations
Semantic Scholar
Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8‐year follow‐up data of 281 patients from the international RIT‐registry
K. Hohloch, C. Windemuth-Kieselbach, J. Kolz, P. Zinzani +5 more
2018British Journal of Haematology9 citations Open access
Semantic Scholar
Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry
K. Hohloch, C. Windemuth-Kieselbach, P. Zinzani, R. Cacchione +4 more
2019Annals of Hematology7 citations Open access
Semantic Scholar
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens
K. Hohloch, S. Zeynalova, G. Held, M. Ziepert +5 more
2014Leukemia6 citations
Semantic Scholar
CHOP/CHOEP-14 followed by consolidation with alemtuzumab in untreated aggressive T-cell lymphomas (DSHNHL 2003-1): Feasibility and toxicity of a phase II trial of the German High Grade Non-Hodgkin's Lymphoma Group DSHNHL.
L. Trumper, K. Hohloch, M. Kloess, U. Duhrsen +7 more
2006Journal of Clinical Oncology6 citations
Semantic Scholar
Osteoblast-like cells with different embryologic origins behave differently in increasing zoledronic acid concentrations: a pilot study in pigs.
P. Kauffmann, W. Hahn, Niklas Sievers, M. Troeltzsch +5 more
2017Oral surgery, oral medicine, oral pathology and oral radiology5 citations
Semantic Scholar
Cerebral salt wasting in a patient with myeloproliferative neoplasm
Lea Orlik, R. Venzin, T. Fehr, K. Hohloch
2018BMC Neurology4 citations Open access
Semantic Scholar
Radioimmunotherapy of lymphoma: an underestimated therapy option.
K. Hohloch
2017The Lancet Haematology4 citations
Semantic Scholar
Radioimmunotherapy Is Safe and Effective in Relapse after Stem Cell Transplantation for B- Cell Non Hodgkins Lymphoma, An Analysis of the International RIT-Network
K. Hohloch, P. Zinzani, W. Linkesch, A. Deptała +5 more
20083 citations
Semantic Scholar
Tandem HD-chemotherapy and myeloablative radioimmunotherapy with 131I-anti-CD20 rituximab in relapsed and refractory B-cell lymphoma: Results of a phase II study of the German RAIT Study Group.
K. Hohloch, G. Wulf, W. Jung, E. Stitz +4 more
2006Journal of Clinical Oncology3 citations
Semantic Scholar
SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS
A. Stathis, U. Mey, S. Schär, F. Hitz +19 more
2019Hematological Oncology2 citations
Semantic Scholar
Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma
K. Hohloch, S. Zeynalova, B. Chapuy, M. Pfreundschuh +7 more
2016Annals of Hematology2 citations
Semantic Scholar
[Aplastic anemia--treatment].
R. Schroers, K. Hohloch, L. Trumper
2003Deutsche Medizinische Wochenschrift2 citations Open access
Semantic Scholar
[Aplastic anemia--case report].
R. Schroers, K. Hohloch, L. Trumper
2003Deutsche Medizinische Wochenschrift2 citations Open access
Semantic Scholar
Radioimmunotherapy for follicular lymphoma achieves excellent lymphoma control in first line and relapse: 8‐year follow‐up data of 281 patients from the international RIT‐registry
K. Hohloch, C. Scholz, C. Windemuth-Kiesselbach, J. Kolz +5 more
20171 citations Open access
Semantic Scholar
Age-dependent analysis of toxicity, mortality, and implementation of an anti-infective prophylaxis in 1171 elderly patients (pts) with aggressive B-cell lymphoma (aNHL): Data from consecutive phase II and III trials of the DSHNHL.
F. Zettl, M. Ziepert, B. Altmann, S. Zeynalova +5 more
20161 citations Open access
Semantic Scholar
Obesity Is a Prognostic Factor in Elderly Female Patients with Aggressive B-Cell Lymphomas Treated with R- CHOP
K. Hohloch, B. Altmann, M. Pfreundschuh, M. Loeffler +3 more
20151 citations
Semantic Scholar
Palliative Care for Patients with Haematological Malignancies
B. Alt-Epping, K. Hohloch
20151 citations
Semantic Scholar
Yttrium‐90 Ibritumomab Tiuxetan (Zevalin®)
K. Hohloch, B. Chapuy, L. Trumper
20141 citations
Semantic Scholar
Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma
I. Schaefer, A. Marx, C. Sauer, K. Hohloch +3 more
2013Histopathology1 citations
Semantic Scholar
SAKK 36 / 13 – Ibrutinib and bortezomib and ibrutinib maintenance for relapsed / refractory mantle cell lymphoma : an ongoing trial
U. Novak, M. Fehr, T. Zander, R. Winterhalder +21 more
20180 citations
Semantic Scholar
Leucemias y linfomas: Diagnóstico y tratamiento
K. Hohloch
20150 citations
Semantic Scholar
Radioimmunotherapy efficiency and safety in consolidation and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: An updated analysis of 230 patients of the international RIT-network.
K. Hohloch, H. K. Lankeit, P. Zinzani, M. Lorsbach +2 more
20120 citations
Semantic Scholar
Radioimmunotherapy for consolidation and relapse therapy for aggressive B-cell non-Hodgkin lymphoma: Retrospective analysis of the International RIT-Network.
K. Hohloch, C. Windemuth-Kiesselbach, Michael Lorsbach, P. Zinzani +1 more
20100 citations
Semantic Scholar
CORRIGENDUM: Population Pharmacokinetics of Melphalan and Glutathione S‐transferase Polymorphisms in Relation to Side Effects
A. Kühne, O. Sezer, U. Heider, I. Meineke +6 more
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Trumper×23
Invite
L. Trumper — researcher profile on SciRah
M. Ziepert×8
Invite
M. Ziepert — researcher profile on SciRah
P. Zinzani×8
Invite
P. Zinzani — researcher profile on SciRah
L. Truemper×5
Invite
L. Truemper — researcher profile on SciRah

×4

Invite

C. Buske — researcher profile on SciRah

Invite

M. Dreyling — researcher profile on SciRah

J. Brockmöller×4

Invite

J. Brockmöller — researcher profile on SciRah

W. Hiddemann×4

Invite

W. Hiddemann — researcher profile on SciRah

Invite

M. Loeffler — researcher profile on SciRah

Invite

G. Wulf — researcher profile on SciRah

Invite

B. Altmann — researcher profile on SciRah

R. Cacchione×4

Invite

R. Cacchione — researcher profile on SciRah